


The Fund aims to achieve a high level of monthly income with prospects for capital growth.
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline PLC | 6.8% | 
| Royal Dutch Shell PLC (CL B) | 6.5% | 
| Vodafone Group PLC | 6.0% | 
| British American Tobacco PLC | 4.8% | 
| BT Group PLC | 3.2% | 
| BP PLC | 3.1% | 
| BG Group PLC | 2.9% | 
| Imperial Tobacco Group PLC | 2.8% | 
| Legal & General Group PLC | 2.7% | 
| HSBC Holdings PLC | 2.2% | 
| Key | % Net Assets | 
|---|---|
| 6.8% | |
| 6.5% | |
| 6.0% | |
| 4.8% | |
| 75.9% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 81.19p | 
| Currency | GBP | 
| Change | 0.12p | 
| % | 0.15% | 
| YTD change | 9.27p | 
| YTD % | 12.89% | 
| Fund Inception | 01/01/1964 | 
|---|---|
| Fund Manager | Jonathan Barber | 
| TER | 1.61 (30-Mar-2012) | 
| Minimum Investment | |
|---|---|
| Initial | £2000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 3.75% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.12 | 
You are here: research